These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 231594

  • 1. Preliminary results of a phase III comparison study of BCNU, hydroxyurea and radiation to BCNU and radiation.
    Levin VA, Wilson CB, Davis R, Wara W, Pischer TL, Irwin L.
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1573-6. PubMed ID: 231594
    [No Abstract] [Full Text] [Related]

  • 2. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
    Levin VA, Wilson CB, Davis R, Wara WM, Pischer TL, Irwin L.
    J Neurosurg; 1979 Oct; 51(4):526-32. PubMed ID: 225456
    [No Abstract] [Full Text] [Related]

  • 3. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):57-63. PubMed ID: 9422558
    [Abstract] [Full Text] [Related]

  • 4. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ, Malkin MG, Kleber M, Abrey LE.
    Neuro Oncol; 2004 Jul 01; 6(3):247-52. PubMed ID: 15279717
    [Abstract] [Full Text] [Related]

  • 5. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
    Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1990 Feb 01; 18(2):321-4. PubMed ID: 2154418
    [Abstract] [Full Text] [Related]

  • 6. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y.
    Cancer; 1983 Sep 15; 52(6):997-1007. PubMed ID: 6349785
    [Abstract] [Full Text] [Related]

  • 7. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB.
    J Neurosurg; 1985 Aug 15; 63(2):218-23. PubMed ID: 2991486
    [Abstract] [Full Text] [Related]

  • 8. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
    Eagan RT, Dinapoli RP, Hermann RC, Groover RV, Layton DD, Scott M.
    Cancer Treat Rep; 1982 Aug 15; 66(8):1647-9. PubMed ID: 7105055
    [No Abstract] [Full Text] [Related]

  • 9. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
    Nelson DF, Schoenfeld D, Weinstein AS, Nelson JS, Wasserman T, Goodman RL, Carabell S.
    Int J Radiat Oncol Biol Phys; 1983 Aug 15; 9(8):1143-51. PubMed ID: 6347995
    [Abstract] [Full Text] [Related]

  • 10. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
    Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O'Fallon JR, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM.
    Cancer; 2001 Jul 15; 92(2):420-33. PubMed ID: 11466698
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Cascino TL, Burch PA, Dinapoli RP.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):297-302. PubMed ID: 9457812
    [Abstract] [Full Text] [Related]

  • 15. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC, Ingle JN, Cascino TL.
    Neurosurgery; 1999 Jan 15; 44(1):67-73. PubMed ID: 9894965
    [Abstract] [Full Text] [Related]

  • 16. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Reid JM, Bagniewski PJ, Ames MM, Cascino TL, Marks RS.
    Int J Radiat Oncol Biol Phys; 1998 Dec 01; 42(5):969-75. PubMed ID: 9869217
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas.
    Levin VA, Phuphanich S, Liu HC, Da Silva V, Murovic J, Choucair A, Chamberlain M, Berger M, Seager M, Davis RL.
    Cancer Treat Rep; 1986 Nov 01; 70(11):1271-4. PubMed ID: 3021325
    [Abstract] [Full Text] [Related]

  • 18. BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
    Levin VA, Hoffman WF, Pischer TL, Seager ML, Boldrey EB, Wilson CB.
    Cancer Treat Rep; 1978 Dec 01; 62(12):2071-6. PubMed ID: 221113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-dose radiation therapy with low-dose (pulsed) BCNU in malignant gliomas: an Eastern Cooperative Oncology Group (ECOG) report.
    Salazar OM, VanHoutte PJ, Bennett JM, Rubin P, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1982 May 01; 8(5):915-9. PubMed ID: 6286558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.